Global “Hormonal Contraceptive Market” report offers an overview of the market size, share, trends, drivers, and barriers with respect to the Hormonal Contraceptive Industry. Latest report on the global Hormonal Contraceptive market is a compilation of key market insights and discusses key market dynamics such as drivers, restraints, and opportunities at length. It also provides a comprehensive overview of the market of different regions across North America, Europe, Asia Pacific, South America, Africa and Others.
The Hormonal Contraceptive
Market report discusses the primary industry growth drivers and challenges that
the vendors and the market as a whole face and provides an overview of the key
trends emerging in the market. It also talks about the market size of different
segments and their growth aspects along with key leading countries in Americas,
Asia-Pacific, Europe, the Middle East, and Africa regions.
Significant Features that
are under Offering and Key Highlights of the Reports:
• Detailed overview of Hormonal
Contraceptive Market
• Changing market dynamics
of the Hormonal Contraceptive industry
• In-depth market
segmentation by Type, Application etc
• Historical, current and
projected market size in terms of volume and value
• Competitive landscape of Hormonal
Contraceptive Market
• Strategies of key players
and product offerings
Get Free PDF Sample (Including Full TOC,
List of Tables & Figures) @ https://www.millioninsights.com/industry-reports/hormonal-contraceptive-market/request-sample
Global Hormonal
Contraceptive Market is expected to reach USD 26.2 billion by 2025. The
hormonal contraceptive is termed as a birth control method, which acts on an
endocrine system. The method is mainly used to prevent ovulation using female
hormones. Progesterone and/or estrogen, or combination of these hormones are
the two main forms of hormonal contraception. These hormones may be implanted
into body tissue, absorbed from a patch on the skin, may be taken orally,
injected under the skin, or placed in the vagina. The Hormonal Contraceptive
Market is estimated to grow at a significant CAGR of 4.0% over the future
period as the scope and its applications are rising enormously across the
globe.
High demand for hormonal
contraception for birth control, growing female population, urbanization and
raised awareness regarding hormonal contraception, and availability of low cost
contraceptive practices are documented as major factors of Hormonal
Contraceptive Market that are estimated to enhance the growth in the years to
come. However, adverse side effects and key barrier for global market are the
factors that may restrain overall market growth in the coming years. Hormonal
Contraceptive Market is segmented based on product type, methods, end use, and
region.
Implantation, oral pill,
injection, skin patch, intrauterine device (IUD), and other products could be
explored in Hormonal Contraceptive Market in the forecast period. Oral pill is
also termed as “the pill” that contains grouping of female hormones, progesterone
and estrogen. The pill helps to prevent the risk of pregnancy by keeping the
lining of the uterus thin and by avoiding ovulation. Intrauterine device (IUD)
is a T-shapes small device, which is implanted into uterus that help to prevent
pregnancy. The effect of device is for many years and can be removed at certain
period. Hormonal IUD and Copper IUD are the two main intrauterine devices.
Sterilization, barrier
method, emergency contraception, and hormonal methods are the methods that
could be explored in Hormonal Contraceptive in the future period. Barrier
method helps to prevent sperm from entering the uterus. Cervical caps,
diaphragms, male condom, female condom, and others are the barrier methods.
Hormonal method use hormones that may be introduced through injections, pills,
vaginal rings, skin patches, and others to stop or regulate ovulation and
prevent pregnancy.
Emergency contraception are
the hormonal pills that are taken with 12 hours as a single dose or a double
dose in case of unprotected intercourse. It helps to inhibit or delay ovulation
for at least 5 days until the sperm become inactive. However, sterilization is
a permanent form of birth control that either prevents a man from releasing
sperm or averts a woman from getting pregnant.
The market may be
categorized based on end users like ambulatory surgical centers, hospitals,
clinics, homecare settings, gynecology centers, and others. Gynecology centers
and hospitals sectors accounted for the majority market share and is estimated
to lead the overall market in the upcoming years. However, other segments are
estimated to grow at fastest pace in the future period.
Globally, North America
accounted for the largest market share of Hormonal Contraceptive in terms of
revenue and is estimated to continue its dominance in the coming years. The
reason behind growth of overall market could be presence of key manufacturers
in the region and comfort of use. Instead, Europe and the Asia Pacific are also
estimated to have a positive influence on the future growth. Europe is the
second largest region with significant market share. However, Asia Pacific is
estimated to grow at fastest pace with the highest CAGR in the foremost period.
The developing countries like India and China are the major consumers of this
market in the region.
The key players of Hormonal
Contraceptive Industry are Teva Pharmaceutical Industries Limited, Bayer Pharma
AG, Agile Therapeutics Inc., Merck & Co., Inc., Charleston, SC., and
Afaxys, Inc. These players are concentrating on inorganic growth to sustain
themselves amongst fierce competition. As such, mergers, acquisitions, and
joint ventures are the need of the hour.
Know More Insights
@ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment